Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00084318
Status:
COMPLETED
Last Update Posted:
2018-12-12
First Post:
2004-06-10
Brief Title:
Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
Sponsor:
Radiation Therapy Oncology Group
Organization:
Radiation Therapy Oncology Group
Organization Data
Organization:
Radiation Therapy Oncology Group
Class:
NETWORK
Study ID:
RTOG-0234
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Radiation Therapy Oncology Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| NRG Oncology | OTHER |
| National Cancer Institute NCI | NIH |